108 filings
Page 3 of 6
8-K
ag62mvaa64 r96
22 Jul 20
AGTC Announces Updated Development Plan for its X-Linked Retinitis
7:18am
8-K
7bbo2k
2 Jul 20
Entry into a Material Definitive Agreement
4:04pm
8-K
ba4qbs uby1
13 May 20
AGTC Announces Financial Results and Business Update for the
7:12am
8-K/A
6po og2z9u
8 Apr 20
Regulation FD Disclosure
4:09pm
8-K
dqpynx3
7 Apr 20
Regulation FD Disclosure
7:02am
8-K
3ezk y1n0g
10 Jan 20
Departure of Directors or Certain Officers
4:20pm
8-K
os1wn nu2zohibo714f
9 Dec 19
Submission of Matters to a Vote of Security Holders
4:44pm
8-K
gc29z
2 Dec 19
AGTC Announces Departure of Chief Medical Officer, Company on Track to Announce XLRP and ACHM Data in January 2020
5:03pm
8-K
6k929nq1r
12 Nov 19
AGTC Announces Financial Results and Business Update for the AGTC Clinical Program Update
4:48pm
8-K
7t1g3prg8jui3607p
26 Sep 19
AGTC Announces Financial Results and Business Update for the Fourth Quarter and Fiscal
4:11pm
8-K
sjeb0xv9awu0jeq
2 Aug 19
Departure of Directors or Certain Officers
4:26pm
8-K
hlepl5jpj 8yig54t
26 Jul 19
Departure of Directors or Certain Officers
6:06am
8-K
kpgpbtvznmer98v6
25 Jun 19
Departure of Directors or Certain Officers
7:11am
8-K
m028h
7 May 19
Results of Operations and Financial Condition
7:01am
8-K
ci7 s0m6apxf1
7 Feb 19
Results of Operations and Financial Condition
7:09am
8-K
ux5j ji2lwah
13 Dec 18
AGTC Announces Topline InterimSix-Month Data from Phase 1/2X-linked Retinoschisis Clinical Study; Termination of Biogen Collaboration
8:26am
8-K
hhwvrw6vhtfyup
19 Nov 18
Submission of Matters to a Vote of Security Holders
4:40pm
8-K
nnrwni08b ima1i
8 Nov 18
Results of Operations and Financial Condition
7:18am
8-K
fvyc0 klgah
24 Sep 18
AGTC Appoints William Aliski to its Board of Directors
5:21pm
8-K
kg29 caf3j
10 Sep 18
Results of Operations and Financial Condition
12:00am